Company: INKT
Filing Date: 2025-12-10
Form Type: S-3/A
Source: 0001193125-25-314252
Chunk: 33

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-12-10
Form: S-3/A
Chunk 33
---
 our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the ATM Sales Agreement, we may offer and sell shares up to $50,000,000 of our common stock from time to time through the Sales Agent. We are subject to the offering limits in General Instruction I.B.6 of Form S-3.As of December 9, 2025, the aggregate market value of our common stock held by non-affiliates,or public float, calculated for purposes of General Instruction I.B.6 of Form S-3is $32,349,220, which was calculated based on 2,159,494 shares of our outstanding common stock held by non-affiliatesas of such date and a price of $14.98 per share, the closing price of our common stock on October 24, 2025, which is the highest closing sale price of our common stock on the Nasdaq Capital Market within the prior 60 days. During the prior 12 calendar month period that ends on and includes the date of this prospectus supplement, we have offered and sold 163,660 shares of common stock for gross proceeds of $5,035,949 pursuant to General Instruction I.B.6 of Form S-3.Pursuant to General Instruction I.B.6 of Form S-3,in no event will we sell securities in public primary offerings on Form S-3with a value exceeding one-thirdof our public float (as defined by General Instruction I.B.6) in any 12-calendarmonth period so long as our public float remains below $75.0 million. As a result of the limitations on the maximum amount of shares that we are eligible to offer and sell under General Instruction I.B.6 of Form S-3,we may currently only offer and sell shares of our common stock having an aggregate offering price of up to $5,747,124 pursuant to the ATM Sales Agreement. However, in the event that our public float increases or decreases, we may sell securities in public primary offerings on Form S-3with a value up to one-thirdof our public float in any 12-calendarmonth period, in each case calculated pursuant to General Instruction I.B.6 and subject to the terms of the ATM Sales Agreement. In the event that our public float increases above $75.0 million, we will no longer be subject to the limits in General Instruction I.B.6 of Form S-3. Our common stock is listed on the Nasdaq